BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2976406)

  • 1. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A; Martín M; Geiger JM; Marrón JM
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J; Geiger JM
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
    Saurat JH; Geiger JM; Amblard P; Beani JC; Boulanger A; Claudy A; Frenk E; Guilhou JJ; Grosshans E; Mérot Y
    Dermatologica; 1988; 177(4):218-24. PubMed ID: 2976000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
    Lassus A; Geiger JM
    Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
    Geiger JM; Czarnetzki BM
    Dermatologica; 1988; 176(4):182-90. PubMed ID: 2967779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis.
    Olsen EA; Weed WW; Meyer CJ; Cobo LM
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):681-6. PubMed ID: 2530251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease.
    Christophersen J; Geiger JM; Danneskiold-Samsoe P; Kragballe K; Larsen FG; Laurberg G; Serup J; Thomsen K
    Acta Derm Venereol; 1992; 72(2):150-2. PubMed ID: 1350407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP; Matt LH; Lowe NJ
    Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
    Ruzicka T; Sommerburg C; Braun-Falco O; Köster W; Lengen W; Lensing W; Letzel H; Meigel WN; Paul E; Przybilla B
    Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side-effect profile of acitretin therapy in psoriasis.
    Gupta AK; Goldfarb MT; Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1989 Jun; 20(6):1088-93. PubMed ID: 2526824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acitretin improves psoriasis in a dose-dependent fashion.
    Goldfarb MT; Ellis CN; Gupta AK; Tincoff T; Hamilton TA; Voorhees JJ
    J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):655-62. PubMed ID: 2967310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etretin. A replacement for etretinate.
    O'Brien TJ
    Int J Dermatol; 1990 May; 29(4):270-1. PubMed ID: 2142483
    [No Abstract]   [Full Text] [Related]  

  • 17. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone.
    Lowe NJ; Prystowsky JH; Bourget T; Edelstein J; Nychay S; Armstrong R
    J Am Acad Dermatol; 1991 Apr; 24(4):591-4. PubMed ID: 1827799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic retinoid therapy for psoriasis.
    Lowe NJ; Lazarus V; Matt L
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
    Ashley JM; Lowe NJ; Borok ME; Alfin-Slater RB
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):76-82. PubMed ID: 2969924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study.
    Tanew A; Guggenbichler A; Hönigsmann H; Geiger JM; Fritsch P
    J Am Acad Dermatol; 1991 Oct; 25(4):682-4. PubMed ID: 1838750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.